Loading company details...
Beta
Latest Form 4 (Sep 8, 2026): Heng Fai Ambrose Chan (Director): Sale of 21,852 shares, $17.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Heng Fai Ambrose Chan | Sale | 21,852 | $17.9K |
| Jul 9, 2026 | Heng Fai Ambrose Chan | Other (see footnotes) | 16,554,055 | $15.40M |
| Sep 3, 2025 | Heng Fai Ambrose Chan | Sale | 130,679 | $176.1K |
| Aug 22, 2025 | Heng Fai Ambrose Chan | Other (see footnotes) | 581,395 | $500.0K |
| Feb 10, 2025 | Heng Fai Ambrose Chan | Grant/Award | 1,000,000 | n/a |
| Dec 13, 2024 | Heng Fai Ambrose Chan | Purchase | 820,597 | $800.0K |
| Jan 2, 2024 | William Wai Leung Wu | Sale | 150,000 | $19.6K |
| Jan 2, 2024 | Heng Fai Ambrose Chan | Purchase | 672,173 | $98.1K |
| Apr 18, 2023 | Frank D. Heuszel, Chief Executive Officer | Grant/Award | 1,247,078 | $270.4K |
| Dec 15, 2022 | Heng Fai Ambrose Chan | Purchase | 334,921 | $75.9K |